GMP IPO Watch
Exchange Traded Funds (ETFs) - Other ETF
Motilal Oswal BSE Healthcare ETF
Motilal Oswal Mutual Fund
Risk: Very High Risk
52W Low ₹41.39 29 Jan 2026
52W High ₹52.93 23 Sept 2026
₹51.8454
NAV as of 4 Nov 2026
+1.02% day change
ISININF247L01BB1
Scheme Code150445
StructureOpen Ended Schemes
AUM (avg. July - September 2026)₹44.15 Cr
Expense Ratio (as of 3 Nov 2026)0.34%
Min. Investment₹500
Inception Date14 Jul 2022
Portfolio Turnover63.03%
Returns
1Y
+14.33%
3Y
+22.85%
Since Inception
+20.75%
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +3.35% | +3.62% | 152 of 229 |
| 1M | +2.36% | +2.76% | 140 of 227 |
| 3M | +0.59% | -3.72% | 17 of 227 |
| 6M | +13.13% | -0.45% | 2 of 218 |
| YTD | +17.18% | -3.05% | 8 of 229 |
| 1Y | +14.33% | -0.32% | 14 of 193 |
| 2Y | +8.27% | +4.05% | 20 of 150 |
| 3Y | +22.85% | +11.19% | 8 of 125 |
| INCEPTION | +20.75% | — | — |
Ranked among: Exchange Traded Funds (ETFs) - Other ETF.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +5.51% | +26.54% | -13.52% | 70% | 29% |
| 6M | +11.51% | +33.62% | -11.41% | 72% | 31% |
| 1Y | +25.27% | +64.22% | -3.90% | 95% | 44% |
| 2Y | +24.77% | +41.43% | +4.23% | 100% | 48% |
| 3Y | +24.07% | +28.44% | +19.48% | 100% | 49% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity99.91%
- Debt0.00%
- Cash0.09%
- Other0.00%
Market Cap Split
- Large Cap33.30%
- Mid Cap38.49%
- Small Cap28.12%
- Others0.09%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 39.18 | — |
| P/B | 5.49 | — |
| Price / Sales | 5.64 | — |
| Price / Cash Flow | 30.00 | — |
| Dividend Yield (%) | 0.56 | — |
Holdings138
Top 5 Stocks34.59%
Top 10 Stocks53.19%
Top 3 Sectors99.91%
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| Sun Pharmaceutical | Pharmaceuticals & Biotechnology | 12.33% | -0.59% |
| Divis Laboratories | Pharmaceuticals & Biotechnology | 7.42% | +0.21% |
| Apollo Hospitals | Equity | 5.21% | -0.32% |
| Laurus Labs | Pharmaceuticals & Biotechnology | 4.84% | +0.37% |
| Cipla | Pharmaceuticals & Biotechnology | 4.79% | -0.11% |
| Dr Reddys Laboratories | Pharmaceuticals & Biotechnology | 4.73% | +0.39% |
| Max Healthcare Institute | Equity | 4.32% | -0.29% |
| Torrent Pharmaceuticals | Pharmaceuticals & Biotechnology | 3.55% | -0.80% |
| Lupin | Pharmaceuticals & Biotechnology | 3.11% | -0.12% |
| Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.89% | +0.01% |
| Fortis Healthcare | Equity | 2.51% | -0.38% |
| Glenmark Pharmaceuticals | Pharmaceuticals & Biotechnology | 2.17% | -0.11% |
| Alkem Laboratories | Pharmaceuticals & Biotechnology | 1.89% | -0.03% |
| Zydus Life Science | Pharmaceuticals & Biotechnology | 1.82% | +0.03% |
| Mankind Pharma | Pharmaceuticals & Biotechnology | 1.75% | +0.11% |
View all 139 holdings
| IPCA Laboratories | Pharmaceuticals & Biotechnology | 1.69% | +0.00% |
| Biocon | Pharmaceuticals & Biotechnology | 1.63% | -0.14% |
| Gland Pharma | Pharmaceuticals & Biotechnology | 1.44% | +0.04% |
| Sai Life Sciences | Pharmaceuticals & Biotechnology | 1.30% | +0.09% |
| Krishna Institute of Medical Sciences | Equity | 1.24% | +0.10% |
| Aster DM Quality Care | Equity | 1.18% | -0.04% |
| Neuland Laboratories | Pharmaceuticals & Biotechnology | 1.16% | -0.05% |
| Wockhardt | Pharmaceuticals & Biotechnology | 1.10% | +0.15% |
| Acutaas Chemicals | Pharmaceuticals & Biotechnology | 1.06% | +0.06% |
| Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.02% | +0.08% |
| Dr. Lal Path Labs | Equity | 0.96% | +0.04% |
| Abbott | Pharmaceuticals & Biotechnology | 0.87% | +0.06% |
| Piramal Pharma | Pharmaceuticals & Biotechnology | 0.81% | -0.01% |
| Narayana Hrudayalaya | Equity | 0.78% | -0.03% |
| Shilpa Medicare | Pharmaceuticals & Biotechnology | 0.77% | +0.09% |
| Granules | Pharmaceuticals & Biotechnology | 0.76% | +0.03% |
| Global Health | Equity | 0.76% | -0.02% |
| Onesource Specialty Pharma | Pharmaceuticals & Biotechnology | 0.75% | +0.03% |
| GlaxoSmithKline Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.71% | -0.05% |
| Rubicon Research | Pharmaceuticals & Biotechnology | 0.67% | +0.32% |
| Anthem Biosciences | Pharmaceuticals & Biotechnology | 0.58% | -0.19% |
| Jubilant Pharmova | Pharmaceuticals & Biotechnology | 0.51% | +0.08% |
| Emcure Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.51% | +0.12% |
| Strides Pharma Science | Pharmaceuticals & Biotechnology | 0.47% | +0.05% |
| Natco Pharma | Pharmaceuticals & Biotechnology | 0.46% | -0.01% |
| Cohance Lifesciences | Pharmaceuticals & Biotechnology | 0.45% | +0.00% |
| Vijaya Diagnostic Centre | Equity | 0.45% | +0.00% |
| Syngene International | Equity | 0.43% | -0.03% |
| Marksans Pharma | Pharmaceuticals & Biotechnology | 0.43% | +0.01% |
| Rainbow Childrens Medicare | Equity | 0.42% | -0.02% |
| Poly Medicure | Equity | 0.39% | -0.01% |
| Indegene | Equity | 0.38% | -0.01% |
| Eris Lifesciences | Pharmaceuticals & Biotechnology | 0.38% | -0.10% |
| Pfizer | Pharmaceuticals & Biotechnology | 0.37% | -0.06% |
| Metropolis Healthcare | Equity | 0.36% | -0.02% |
| Caplin Point Laboratories | Pharmaceuticals & Biotechnology | 0.34% | +0.04% |
| Aarti Pharma Labs | Pharmaceuticals & Biotechnology | 0.31% | +0.04% |
| Jupiter Life Line Hospital | Equity | 0.30% | -0.04% |
| Concord Biotech | Pharmaceuticals & Biotechnology | 0.29% | -0.01% |
| Bliss GVS Pharma | Pharmaceuticals & Biotechnology | 0.29% | +0.04% |
| Alembic Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.29% | +0.01% |
| Procter & Gamble Health | Pharmaceuticals & Biotechnology | 0.28% | +0.00% |
| Yatharth Hospital | Equity | 0.28% | +0.02% |
| Morepen Laboratories | Pharmaceuticals & Biotechnology | 0.27% | +0.04% |
| Alivus Life Sciences | Pharmaceuticals & Biotechnology | 0.27% | +0.01% |
| Corona Remedies | Pharmaceuticals & Biotechnology | 0.25% | +0.17% |
| AstraZeneca Pharma | Pharmaceuticals & Biotechnology | 0.24% | -0.03% |
| Viyash Scientific | Pharmaceuticals & Biotechnology | 0.23% | -0.02% |
| Dr. Agarwal's Health Care | Equity | 0.23% | -0.01% |
| Healthcare Global Enterprises | Equity | 0.22% | -0.02% |
| Senores Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.22% | +0.00% |
| Thyrocare Technologies | Equity | 0.21% | -0.02% |
| Akums Drugs & Pharma | Pharmaceuticals & Biotechnology | 0.18% | +0.02% |
| Kovai Medical Center Hospital | Equity | 0.17% | +0.00% |
| Sanofi | Pharmaceuticals & Biotechnology | 0.17% | +0.00% |
| Sanofi Consumer Healthcare | Pharmaceuticals & Biotechnology | 0.16% | -0.01% |
| Supriya Lifescience | Pharmaceuticals & Biotechnology | 0.15% | +0.02% |
| Nephrocare Health Services | Equity | 0.15% | +0.06% |
| Suven Life Sciences | Equity | 0.15% | -0.03% |
| IOL Chemicals & Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.15% | +0.01% |
| Blue Jet Healthcare | Pharmaceuticals & Biotechnology | 0.13% | +0.01% |
| Park Medi World | Equity | 0.13% | +0.03% |
| Ind Swift Laboratories | Pharmaceuticals & Biotechnology | 0.12% | — |
| Sun Pharma Advanced Research Co | Pharmaceuticals & Biotechnology | 0.12% | +0.00% |
| Innova Captab | Pharmaceuticals & Biotechnology | 0.12% | +0.01% |
| Solara Active Pharma Sciences | Pharmaceuticals & Biotechnology | 0.11% | +0.02% |
| Artemis Medicare Services | Equity | 0.11% | +0.01% |
| FDC | Pharmaceuticals & Biotechnology | 0.10% | +0.00% |
| Kwality Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.10% | +0.01% |
| Indraprastha Medical Corporation | Equity | 0.10% | +0.00% |
| Aarti Drugs | Pharmaceuticals & Biotechnology | 0.10% | +0.01% |
| Orchid Pharma | Pharmaceuticals & Biotechnology | 0.10% | +0.01% |
| SMS Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.09% | +0.02% |
| Novartis | Pharmaceuticals & Biotechnology | 0.09% | +0.02% |
| Venus Remedies | Pharmaceuticals & Biotechnology | 0.09% | — |
| Net Receivables / (Payables) | Net Current Assets | 0.09% | — |
| Shukra Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.08% | — |
| Advanced Enzyme Tech | Pharmaceuticals & Biotechnology | 0.08% | +0.00% |
| RPG Life Sciences | Pharmaceuticals & Biotechnology | 0.08% | +0.01% |
| Gujarat Themis Biosyn | Pharmaceuticals & Biotechnology | 0.08% | +0.00% |
| Gufic BioSciences | Pharmaceuticals & Biotechnology | 0.07% | +0.00% |
| Syncom Formulations | Pharmaceuticals & Biotechnology | 0.07% | +0.02% |
| Unichem Laboratories | Pharmaceuticals & Biotechnology | 0.07% | +0.00% |
| Krsnaa Diagnostics | Equity | 0.06% | +0.00% |
| Dishman Carbogen Amcis | Pharmaceuticals & Biotechnology | 0.06% | -0.01% |
| Fredun Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.06% | — |
| Indoco Remedies | Pharmaceuticals & Biotechnology | 0.06% | +0.01% |
| Vimta Labs | Equity | 0.06% | +0.00% |
| Anlon Healthcare | Pharmaceuticals & Biotechnology | 0.05% | — |
| 3B BlackBio DX | Equity | 0.05% | +0.01% |
| Hester Biosciences | Pharmaceuticals & Biotechnology | 0.05% | +0.00% |
| Windlas Biotech | Pharmaceuticals & Biotechnology | 0.05% | +0.00% |
| Fischer Medical Ventures | Equity | 0.05% | +0.00% |
| Hikal | Pharmaceuticals & Biotechnology | 0.05% | +0.00% |
| Amrutanjan Health Care | Pharmaceuticals & Biotechnology | 0.05% | — |
| Kopran | Pharmaceuticals & Biotechnology | 0.05% | +0.01% |
| Suraksha Diagnostic | Equity | 0.04% | +0.00% |
| Sigachi Industries | Pharmaceuticals & Biotechnology | 0.04% | -0.01% |
| KMC Speciality Hospitals | Equity | 0.04% | +0.01% |
| Sai Parenteral's | Pharmaceuticals & Biotechnology | 0.04% | — |
| Dr. Agrawals Eye Hospital | Equity | 0.04% | +0.00% |
| Panacea Biotec | Pharmaceuticals & Biotechnology | 0.04% | +0.00% |
| Lincoln Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.04% | +0.00% |
| Fermenta Biotech | Pharmaceuticals & Biotechnology | 0.03% | +0.00% |
| Tarsons Products | Equity | 0.03% | +0.00% |
| NGL Fine Chem | Pharmaceuticals & Biotechnology | 0.03% | — |
| GPT Healthcare | Equity | 0.03% | +0.00% |
| Bajaj HealthCare | Pharmaceuticals & Biotechnology | 0.03% | +0.01% |
| Jagsonpal Pharmaceuticals | Pharmaceuticals & Biotechnology | 0.03% | +0.00% |
| Gujarat Kidney and Super Speciality | Equity | 0.02% | +0.00% |
| Wanbury | Pharmaceuticals & Biotechnology | 0.02% | -0.01% |
| Shalby | Equity | 0.02% | -0.01% |
| Laxmi Dental | Equity | 0.02% | +0.00% |
| Themis Medicare | Pharmaceuticals & Biotechnology | 0.02% | +0.00% |
| One Global Service Provider | Equity | 0.02% | — |
| Kilitch Drugs | Pharmaceuticals & Biotechnology | 0.02% | — |
| Medicamen Biotech | Pharmaceuticals & Biotechnology | 0.02% | — |
| Anuh Pharma | Pharmaceuticals & Biotechnology | 0.02% | +0.01% |
| Gaudium IVF & Women Health | Equity | 0.01% | — |
| Fabtech Technologies | Equity | 0.01% | +0.00% |
| Ambalal Sarabhai Enterprises | Pharmaceuticals & Biotechnology | 0.01% | — |
| TAKE | Equity | 0.01% | — |
| Gennex Laboratories | Pharmaceuticals & Biotechnology | 0.01% | — |
| Medico Remedies | Pharmaceuticals & Biotechnology | 0.00% | — |
Sector Allocation · Sep 2026
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 13.59 | 16.71 | Low Volatility |
| 3Y | 14.19 | 15.13 | Low Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 0.54 | -3.33 | Above Average |
| 3Y | 1.03 | -1.59 | Above Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 1.59 | 0.07 | Above Average |
| 3Y | 2.24 | 2.33 | Below Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Beta
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 1.01 | 0.96 | Poor Risk Adjusted Returns |
| 3Y | 1.00 | 0.96 | Poor Risk Adjusted Returns |
What is this?
This value gives idea about how volatile fund performance has been compared to similar funds in the market. Lower beta implies the fund gives more predictable performance compared to similar funds in the market.
Tracking Difference
1Y-0.22%
3Y-0.31%
Since Inception-0.32%
Versus BSE Health Care - TRI, as of Sep 2026.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
| Motilal Oswal Nasdaq Q50 ETF | +33.42% | +31.36% | — | +12.73% |
| Tata Silver Exchange Traded Fund | +26.44% | — | — | +39.36% |
|
SBI Silver ETF
Regular Plan · Growth
|
+26.42% | — | — | +34.10% |
| Kotak Silver ETF | +26.35% | +36.48% | — | +28.03% |
| ICICI PRUDENTIAL SILVER ETF | +26.35% | +36.57% | — | +24.10% |
| Edelweiss Silver ETF | +26.32% | — | — | +35.41% |
| Motilal Oswal Silver ETF | +26.09% | — | — | +46.27% |
|
Nippon India Silver ETF
Direct Plan
|
+26.05% | +36.23% | — | +25.08% |
|
HDFC Silver ETF
Growth Option
|
+25.77% | +36.06% | — | +34.08% |
|
Nippon India Nifty Pharma ETF
Direct Plan
|
+22.83% | +22.93% | +15.06% | +13.35% |
More From Motilal Oswal Asset Management Company Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
| Motilal Oswal Nasdaq Q50 ETF | +33.42% | +31.36% | — | +12.73% |
| Motilal Oswal Silver ETF | +26.09% | — | — | +46.27% |
|
Motilal Oswal Focused Fund
Direct Plan · Growth
|
+23.26% | +15.09% | +10.62% | +14.63% |
|
Motilal Oswal Nasdaq 100 Fund of Fund
Direct plan · Growth
|
+20.65% | +33.60% | +19.63% | +25.03% |
|
Motilal Oswal Developed Market Ex US ETFs Overseas Equity Passive FOF
Direct Plan · Growth
|
+20.26% | +21.92% | — | +21.61% |
|
Motilal Oswal Nifty Capital Market Index Fund
Direct Plan · Growth
|
+20.03% | — | — | +16.81% |
| Motilal Oswal Nifty Capital Market ETF | +20.03% | — | — | +45.83% |
|
Motilal Oswal Gold and Silver Passive Fund of Funds
Direct Plan · Growth
|
+18.31% | +31.69% | — | +28.72% |
|
Motilal Oswal S&P 500 Index Fund
Direct Plan · GROWTH
|
+18.19% | +25.74% | +16.20% | +20.46% |
|
Motilal Oswal Active Momentum Fund
Direct Plan · Growth
|
+17.75% | — | — | +23.84% |
About This Scheme
Investment Objective
The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the S&P BSE Healthcare Total Return Index, subject to tracking error. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved.
Official Documents
Scheme Information Document (PDF)
Scheme Summary (PDF)
Scheme Summary (XLS)
Motilal Oswal Asset Management Company Limited website
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.